Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas

Overview of attention for article published in Cancer Management and Research, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 11,219 followers.

RT @NK_papers: Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and sa…

26 Dec 2018

Reply Repost Favourite

RT @Lymphoma_Papers: Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity…

26 Dec 2018

Reply Repost Favourite

Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas. by Allen PB, Lechowicz MJ https://t.co/vYJqsvrtXv

26 Dec 2018

Reply Repost Favourite

Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas. #lymphoma #lymsm https://t.co/yOPFxiY7JO

26 Dec 2018

Reply Repost Favourite

Dove Medical Press

Article Metrics

Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas

About this Attention Score

Mentioned by

Citations

Readers on